Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Huang, Long ^a,b   Lin, Jia Xin ^a,b   Yu, Yan Hong ^c   Zhang, Mei Yin ^a   Wang, Hui Yun ^a   Zheng, Min ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 10B; MICRORNA 125B; MICRORNA 143; MICRORNA 145; MICRORNA 199A 5P; MICRORNA LET 7C; UNCLASSIFIED DRUG; PRIMER DNA; RNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EARLY CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS; RADICAL HYSTERECTOMY; SMALL CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX SMALL CELL CARCINOMA; GENETICS; KAPLAN MEIER METHOD; METASTASIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; UTERINE CERVIX TUMOR;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SMALL CELL; DNA PRIMERS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, NEOPLASM; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84863344858     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033762     Document Type: Article

References (44)

1. Tsunoda S, Jobo T, Aria M, Imai M, Kanai T, et al. (2005) Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer 15: 295-300.
2. Chung HH, Jang MJ, Jung KW, Won YJ, Shin HR, et al. (2006) Cervical cancer incidence and survival in Korea 1993-2002. Int J Gynecol Cancer 16: 1833-1838.
3. Crowder S, Tuller E, (2007) Small cell carcinoma of the female genital tract. Semin Oncol 34: 57-63.
4. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, et al. (2004) Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93: 27-33.
5. Sevin BU, Method MW, Nadji M, Lu Y, Averette HA, (1996) Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 77: 1489-93.
6. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ, (2003) Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 97: 568-574.
7. Sheets EE, Berman ML, Hrountas CK, Liao SY, Disaia PJ, (1988) Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 71: 10-14.
8. Gersell DJ, Mazoujian G, Mutch DG, Rudoff MA, (1988) Small-cell undifferentiated carcinoma of the cervix: a clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol 12: 684-698.
9. Van Nagell JR, Donaldson ES, Wood EG, Maruyama Y, Utley J, (1977) Small cell cancer of the uterine cervix. Cancer 40: 2243-2249.
10. Sevin BU, Method MW, Nadji M, Lu Y, Arerette HA, (1996) Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 77: 1489-1493.
11. Pazdur R, Bonomi P, Slayton R, Gould VE, Miller A, (1981) Neuroendocrine carcinoma of the cervix: implications for staging and therapy. Gynecol Oncol 12: 120-128.
12. Cummins JM, Velculescu VE, (2006) Implications of micro-RNA profiling for cancer diagnosis. Oncogene 25: 6220-6227.
13. Croce CM, Calin GA, (2005) miRNAs, cancer, and stem cell division. Cell 122: 6-7.
14. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13 (1): 48-57.
15. He L, Thomson JM, Hemann MT, Hernando-Monge E, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
16. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, et al. (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
17. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (11): 2348-2360.
18. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19 (2): 232-243.
19. Kim YB, Barbuto D, Lagasse LD, Karlan BY, (1996) Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to regional lymph nodes. Gynecol Oncol 62 (3): 411-414.
20. Balderston KD, Tewari K, Gregory WT, Berman ML, Kucera PR, (1998) Neuroendocrine small cell uterine cervix cancer in pregnancy: long-term survival following combined therapy. Gynecol Oncol 71 (1): 128-132.
21. Korcum AF, Aksu G, Bozcuk H, Pestereli E, Simsek T, (2008) Small cell carcinoma of the cervix: a case report. Arch Gynecol Obstet 277 (4): 367-370.
22. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, et al. (2004) Microarray-based highthroughput gene expression profiling of microRNAs. Nat. Methods 1: 155-161.
23. Li J, Smyth P, Flavin R, Cahill S, Denning K, et al. (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7: 36.
24. Gotte M, Mohr C, Koo CY, Stock C, Vaske AK, et al. (2010) miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 29: 6569-6580.
25. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, et al. (2009) Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 77: 12-21.
26. Varnholt H, Drebber U, Schulze F, Wedemever I, Schivmacher P, et al. (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 1223-1232.
27. Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, et al. (2009) Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res 15: 1177-1183.
28. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
29. Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, et al. (2009) MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 94: 320-323.
30. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695.
31. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374.
32. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, et al. (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706.
33. Chen X, Guo X, Zhang H, Xiang Y, Chen J, et al. (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-1392.
34. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, Deangelis T, et al. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282: 32582-32590.
35. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, et al. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 106: 3207-3212.
36. Gregersen LH, Jacobsen AB, Frankel LB, (2010) MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 5: e8836.
37. Peng X, Guo W, Liu T, (2011) Identification of miRs-143 and-145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT. PLoS One 6 (5): e20341.
38. Kulda V, Pesta M, Topolcan O, Liska V, Treska V, et al. (2010) Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 200 (2): 154-160.
39. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374.
40. Sachdeva M, Mo YY, (2010) miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res 2: 170-180.
41. Nagayama K, Kohno T, Sato M, Arai Y, Minna JD, et al. (2007) Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosomes Cancer pp. 1000-1010.
42. Shen Q, Cicinnati VR, Zhang X, Lacobs S, Weber F, et al. (2010) Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer 9: 227.
43. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19 (2): 232-243.
44. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111: 3183-3189.